These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37182804)

  • 21. Tumor-targeting oxidative stress nanoamplifiers as anticancer nanomedicine with immunostimulating activity.
    Song N; Park M; Kim N; Lee Y; Jung E; Lee D
    Biomater Sci; 2022 Oct; 10(21):6160-6171. PubMed ID: 36222413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual pH-sensitive oxidative stress generating micellar nanoparticles as a novel anticancer therapeutic agent.
    Park S; Kwon B; Yang W; Han E; Yoo W; Kwon BM; Lee D
    J Control Release; 2014 Dec; 196():19-27. PubMed ID: 25278257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
    Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
    Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy.
    Yu N; Liu T; Zhang X; Gong N; Ji T; Chen J; Liang XJ; Kohane DS; Guo S
    Nano Lett; 2020 Jul; 20(7):5465-5472. PubMed ID: 32573235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
    Liang B; Zhou D
    Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
    Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
    Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
    Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
    Chang N; Zhao Y; Ge N; Qian L
    Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction-sensitive polymeric micelles as amplifying oxidative stress vehicles for enhanced antitumor therapy.
    Xia H; Liang Y; Chen K; Guo C; Wang M; Cao J; Han S; Ma Q; Sun Y; He B
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111733. PubMed ID: 33862572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of a system x
    Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
    J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
    Edupuganti VVSR; Tyndall JDATDA; Gamble AB
    Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safe Laccase@ZIF-8-prodrug system with GSH redox cycle for effective targeted cancer therapy with low off-target toxicity.
    Zhou Y; Zhang C; Wang Y; Zhang J; Yan X; You S; Qi W; Su R; He Z
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112853. PubMed ID: 36215892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinone-methide species, a gateway to functional molecular systems: from self-immolative dendrimers to long-wavelength fluorescent dyes.
    Gnaim S; Shabat D
    Acc Chem Res; 2014 Oct; 47(10):2970-84. PubMed ID: 25181456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-immolative polymer-based immunogenic cell death inducer for regulation of redox homeostasis.
    Jeon J; Yoon B; Dey A; Song SH; Li Y; Joo H; Park JH
    Biomaterials; 2023 Apr; 295():122064. PubMed ID: 36827894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
    Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
    Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.